Associate Professor of Medicine, Beth Israel Deaconess Medical Center
Rheumatology
Dr. David E. Trentham, MD
|
|
Give Review
David Trentham practices Rheumatology. He went to medical school at University of Tennessee College of Medicine. He received 1 awards: "Elected Member". David Trentham is also a published doctor. He has 100 publication published. The most recent publication is: Minocycline in early diffuse scleroderma.
Publications
- Relapsing polychondritis: prevalence of expiratory CT airway abnormalities.
- Letter: Roentgenographic prevalence of chondrocalcinosis.
- Polyneuropathy and anasarca: evidence for a new connective-tissue syndrome and vasculopathic contribution.
- Letter: Berry aneurysms and lupus.
- POEMS syndrome with myocardial infarction: observations concerning pathogenesis and review of the literature.
- Photochemotherapy in systemic sclerosis. The stage is set.
- Novel immunomodulating and immunotherapies, and novel therapies and strategies for inflammatory arthropathy.
- Anti-arthritic effects demonstrated by an interleukin-2 receptor-targeted cytotoxin (DAB486IL-2) in rat adjuvant arthritis.
- Correlation between antibodies to type II collagen and treatment outcome in bilateral progressive sensorineural hearing loss.
- Immunotherapy and other novel therapies.
- Intractable vasculitis, resorptive osteolysis, and immunity to type I collagen in type VIII Ehlers-Danlos syndrome.
- Synovial fluid tests. What should be ordered?
- Novel therapies.
- Measurement of joint inflammation in rheumatoid arthritis with indium-111 chloride.
- Collagen arthritis in the rat is initiated by CD4+ T cells and can be amplified by iron.
- Clues provided by animal models of arthritis.
- Progress in the understanding of inducible models of chronic arthritis.
- Activation of rat synovium by iron.
- Intraarticular injection of arthritogenic factor causes mast cell degranulation, inflammation, fat necrosis, and synovial hyperplasia.
- Attenuation of collagen arthritis and modulation of delayed-type hypersensitivity by type II collagen reactive T-cell lines.
- 2,000-centiGray total lymphoid irradiation for refractory rheumatoid arthritis.
- Diminution of the T8 subset by amiprilose hydrochloride in refractory RA.
- Potential of indium-111 to measure inflammatory arthritis.
- Cyclosporin A treatment of refractory rheumatoid arthritis.
- An arthritogenic lymphokine in the rat.
- Efficacy of low-dose methotrexate in rheumatoid arthritis.
- Total lymphoid irradiation in tertiary care for rheumatoid arthritis.
- Antigen-specific suppression of type II collagen-induced arthritis by collagen-coupled spleen cells.
- Antigen-specific suppression of collagen arthritis by adoptive transfer of spleen cells.
- Collagens act as ligands to stimulate human monocytes to produce mononuclear cell factor (MCF) and prostaglandins (PGE2).
- Strategies for medical treatment based on current understanding of the pathogenesis of rheumatoid arthritis.
- HLA-DR4 is not a requisite for autoimmunity to collagen in rheumatoid arthritis.
- Connective tissue disease can develop in rats either spontaneously or after total lymphoid irradiation.
- Suppressive effects of anti-mu serum on the development of collagen arthritis in rats.
- Immunity to type II collagen in rheumatoid arthritis: a current appraisal.
- Dietary fish oil augments the induction of arthritis in rats immunized with type II collagen.
- Attenuation of an adjuvant arthritis by type II collagen.
- Total lymphoid irradiation therapy in refractory rheumatoid arthritis. Fifteen- to forty-month followup.
- Effect of antithymocyte serum on collagen arthritis in rats: evidence that T cells are involved in its pathogenesis.
- Exacerbation of collagen arthritis by noise stress.
- Gold does not alter the arthritic, humoral, or cellular responses in rats with type II collagen-induced arthritis.
- Dimethyl sulfoxide does not suppress the clinical manifestations of collagen arthritis.
- Collagens stimulate the production of mononuclear cell factor (MCF) and prostaglandins (PGE2) by human monocytes.
- Drug-induced lupus: an adjuvant disease?
- Clinical and immunologic effects of fractionated total lymphoid irradiation in refractory rheumatoid arthritis.
- Autoimmunity induced by type II collagen-coupled spleen cells.
- Autoimmunity to collagen: a shared feature of psoriatic and rheumatoid arthritis.
- Type II collagen-induced auricular chondritis.
- Modulation of human lymphocyte function by C3a and C3a(70-77).
- Collagen arthritis as a relevant model for rheumatoid arthritis.
- Morphologic demonstration of two stages in the development of type II collagen-induced arthritis.
- Immunosuppression by fractionated total lymphoid irradiation in collagen arthritis.
- Augmentation of collagen arthritis by synthetic analogues of retinoic acid.
- Effect of psychological stress on the induction of arthritis in rats.
- Rat leukocyte inhibitory factor (LIF): similarities to human LIF and generation by cells from rats with collagen-induced arthritis.
- Fractionated total lymphoid irradiation can induce temporary relief in refractory rheumatoid arthritis.
- Autoimmunity to collagen in adjuvant arthritis of rats.
- Interleukin-2 diphtheria fusion protein (DAB486IL-2) in refractory rheumatoid arthritis. A double-blind, placebo-controlled trial with open-label extension.
- Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.
- Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens.
- Pathogenesis of rheumatoid arthritis.
- Association between bovine collagen dermal implants and a dermatomyositis or a polymyositis-like syndrome.
- DAB486IL-2 fusion toxin in refractory rheumatoid arthritis.
- Effects of oral administration of type II collagen on rheumatoid arthritis.
- New focus on treatment for rheumatoid arthritis.
- The effect of minocycline in rat models of inflammatory arthritis: correlation of arthritis suppression with enhanced T cell calcium flux.
- Evidence that type II collagen feeding can induce a durable therapeutic response in some patients with rheumatoid arthritis.
- Antibiotic therapy for rheumatoid arthritis. Scientific and anecdotal appraisals.
- A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis.
- HLA-DRB1 genes and disease severity in rheumatoid arthritis. The MIRA Trial Group. Minocycline in Rheumatoid Arthritis.
- Another look at minocycline.
- Meaningful improvement criteria sets in a rheumatoid arthritis clinical trial. MIRA Trial Group. Minocycline in Rheumatoid Arthritis.
- Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) Trial.
- A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis ...
- Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial.
- Oral tolerization as a treatment of rheumatoid arthritis.
- Minocycline in early diffuse scleroderma.
- Relapsing polychondritis and airway involvement.
- Pulmonary manifestations of relapsing polychondritis.
- Novel therapies: apheresis, total nodal irradiation, cytokines, and diet modification.
- Iron, iron-binding proteins and immune system cells.
- Altered immune response in adult women exposed to diethylstilbestrol in utero.
- Obituary for an organization.
- Treatment of rheumatic disease by tumor necrosis factor-alpha blockade: knowns and unknowns.
- Amiprilose hydrochloride for the treatment of rheumatoid arthritis.
- Experimental synovitis induced by collagen-specific T cell lines.
- Evaluation of a modified hexose sugar, amiprilose hydrochloride, in experimental models of synovitis.
- Rheumatologic therapy for the 1990s. Evolution or revolution?
- Prolonged improvement in refractory rheumatoid arthritis after antithymocyte globulin therapy of brief duration.
- The immunopathogenesis of rheumatoid arthritis.
- Collagen arthritis in rats, arthritogenic lymphokines and other aspects.
- Adverse reactions to bovine collagen implants. Additional evidence for immune response gene control of collagen reactivity in humans.
- Cellular immunity to sperm in infertile women.
- Detection of arthritogenic factor in adjuvant arthritis.
- Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis.
- Passive transfer by cells of type II collagen-induced arthritis in rats.
- Cellular sensitivity to collagen in rheumatoid arthritis.
- Abrogation of type II collagen-induced arthritis in rats by psychological stress.
- Humoral and cellular sensitivity to collagen in type II collagen-induced arthritis in rats.
Schools
University Of Tennessee Health Science Center College Of Medicine
Memphis City Hosps
University Tenn
Doctors Specialties
- Internal Medicine
- Rheumatology
Accepted Insurances
Awards
- Elected Member
Education
-
University of Tennessee -
University of Tennessee College of Medicine
Hospital
-
Beth Israel Deaconess Medical Center
Helpful Reviews
Similar Doctors
|
|
Eric J. Amante |
|
|
Dr. Konstantinos Loupasakis, MD |
|
|
Dr. Amy B. Devlin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sonali P. Desai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael E. Weinblatt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Poushali Bhattacharjee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tiffany M. Powell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jordan S. Leyton-Mange, MD |
|
|
Dr. Aarti Asnani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marat Yanavitski, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. K F. Austen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mustafa M. Khaled, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David W. Gray, MD
This Doctor is OpenDoctor Recommended.
|